Kala Bio Inc
(NAS:KALA)
$
6.72
-0.1375 (-2.01%)
Market Cap: 30.98 Mil
Enterprise Value: 19.45 Mil
PE Ratio: 0
PB Ratio: 4.51
GF Score: 46/100 Kala Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023 / 03:55PM GMT
Release Date Price:
$14.48
(-3.21%)
Chris Howerton
(Trades, Portfolio) LLC - Analyst
Okay. Hi, everybody. Thank you so much for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team. Very excited to see everybody here at our healthcare conference for the third day. And we are hosting a fireside chat with our next company, Kala Pharmaceuticals.
And on behalf of the company, we have Kim Brazzell, the CMO. Thanks for joining us here.
Kim Brazzell;Chris Howerton
Kala Pharmaceuticals, Inc - Head, R&D & Chief Medical Officer; (
It's great to be here. My colleague, Todd Bazemore couldn't make it because flight got canceled, because of the smoke.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot